- Report
- July 2024
- 288 Pages
Global
From €5297EUR$5,990USD£4,350GBP
- Report
- June 2019
- 18 Pages
Global
€9154EUR$10,000USD£7,780GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €458EUR$500USD£389GBP
Prezista is a medication used to treat HIV and hepatitis C infections. It is a protease inhibitor, meaning it works by blocking the action of a specific enzyme that is needed for the virus to replicate. Prezista is used in combination with other antiretroviral drugs to treat HIV infection and is also used to treat chronic hepatitis C infection. It is typically prescribed to patients who have not responded to other treatments or who have developed resistance to other medications.
Prezista is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Other companies in the market include Gilead Sciences, AbbVie, Bristol-Myers Squibb, and Merck & Co. Show Less Read more